Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
- Roche plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs, as announced by spokesperson Rebekka Schnell.
- The investment will expand Roche’s manufacturing capabilities and enhance research and development sites in California, Indiana, Massachusetts, and Pennsylvania, according to Roche's statement.
- Roche CEO Thomas Schinecker stated that the investment underscores their commitment to U.S. Manufacturing and research.
- The move comes amid U.S. President Donald Trump's tariff threats, which have impacted the pharmaceutical industry.
142 Articles
142 Articles
Mainstream Media Won't Tell You About the New Drug Factories
Do you know who our major trading partners are? The answer is Switzerland at number one, and Mexico at number two. Switzerland is the home of La Roche Pharmaceuticals. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. They plan to build more of their […] The post Mainstream Media Won’t Tell You About the New Drug Factories appeared first on www.independentsentinel.co…
Coverage Details
Bias Distribution
- 45% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage